Liver Transplantation and Metastatic Colo-rectal Cancer.
Phase 2 Unknown
25 enrolled
IPOS
Phase 2 Unknown
68 enrolled
CETIDYL
Phase 2 Unknown
72 enrolled
FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced Stage
Phase 2 Unknown
30 enrolled
CIFOXRC
Phase 2 Unknown
66 enrolled
To Determine the Efficacy and Safety of Envafolimab Combined With XELOX for Locally Advanced Colon Cancer
Phase 2 Unknown
36 enrolled
Intravenous Iron Infusion on Chemotherapy-induced Anemia
Phase 2 Unknown
80 enrolled
Immunotherapy Versus Chemotherapy as Adjuvant Therapy for Colon Cancer With MSI-H or POLE/ POLD1 Mutations
Phase 2 Unknown
30 enrolled
Neoadjuvant FOLFOXIRI Chemotherapy in Patients With Locally Advanced Colon Cancer
Phase 2 Unknown
30 enrolled
Tislelizumab Plus Anlotinib for Immunotherapy Resistant Gastrointestinal Cancer
Phase 2 Unknown
40 enrolled
SGM-CLM
Phase 2 Unknown
10 enrolled
AVETUXIRI
Phase 2 Unknown
59 enrolled
Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial
Phase 2 Unknown
50 enrolled
Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal Cancer
Phase 2 Unknown
82 enrolled
ECKINOXE
Phase 2 Unknown
186 enrolled
A Phase â…¡ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients
Phase 2 Unknown
130 enrolled
Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Unknown
Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver
Phase 2 Unknown
20 enrolled
Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer
Phase 2 Unknown
Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer
Phase 2 Unknown
225 enrolled
Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer
Phase 2 Unknown
46 enrolled
CIKCC
Phase 2 Unknown
210 enrolled
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
Phase 2 Unknown
60 enrolled
S-1 and Bevacizumab in Treating Patients With Colorectal Cancer That is Recurrent or Cannot Be Removed by Surgery
Phase 2 Unknown
40 enrolled
Cetuximab and Simvastatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
Phase 2 Unknown
51 enrolled
Standard and High Dose Irinotecan Based on UGT1A1 Genotype for First-line Treatment of Locally Advanced Colon Cancer
Phase 2 Unknown
100 enrolled
Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer
Phase 2 Unknown
100 enrolled
Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Unknown
47 enrolled
Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer
Phase 2 Unknown
A Study With Health Educational Material on Health Promotion in Cancer Survivors
Phase 2 Unknown
326 enrolled
Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery
Phase 2 Unknown
35 enrolled
Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin
Phase 2 Unknown
206 enrolled
UFUR
Phase 2 Unknown
34 enrolled
Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Unknown
Neoadjuvant Radiation Therapy and Capecitabine in Treating Patients With Stage III or Stage IV Colorectal Adenocarcinoma
Phase 2 Unknown
Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Unknown
Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer
Phase 2 Unknown
DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Unknown
Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
Phase 2 Unknown
78 enrolled
IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma
Phase 2 Unknown
30 enrolled
Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer
Phase 2 Unknown